AKBA: Akebia Therapeutics, Inc.
Performance
AKBA -73.88%
Watchlist
Select an item
Summary
AKBA at a glance
AKBA returned -73.88% over the past year and -28.82% a year over five years. Its worst drop in that year was -80.33%, smaller than 2% of stocks on Redstone, and its Sharpe ratio of -1.04 beats 4% of stocks on Redstone. It pays no dividends.
Current Drawdown
-73.88%
Rolling Volatility
199.30%
Actions
Metrics
Risk Indicators
Alpha-116.87%
Beta2.29x
Sharpe-1.04
Sortino-1.33
Omega0.81
Calmar-0.92
Martin-2.19
Profile
About AKBA
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $148M
- Listed
- Mar 2014
- Employees
- 194
- Headquarters
- Cambridge, MA
- Website
- akebia.com
Comparisons